11:25am ET
Health and Healthcare
The Bullish and Bearish Case for Pfizer in 2015
One key consideration for the year ahead is that the Pfizer of 2016 or 2017 is likely to be night and day different from the Pfizer of 2005.
Companies
/Healthcare
Merck & Co Inc
$143.93
▼ $0.78 (−0.54%) today
Markets closed · 12:00am ET
MRK Coverage
Page 49
11:35am ET
Health and Healthcare
The Bullish and Bearish Case for Merck in 2015
One key consideration for the year ahead is Merck's acquisitions of Idenix and Cubist Pharmaceuticals to expand its product offerings
Paul Ausick 8:15am ET
Companies and Brands
The Bullish and Bearish Case for Johnson & Johnson in 2015
One key consideration for the year ahead is that Johnson & Johnson raised its dividends again and managed to have upside performance above what was expected.
4:01pm ET
Investing
The 4 Stocks That Lifted the DJIA on Wednesday
thinkstockJanuary 7, 2015: Markets opened higher on Wednesday after ADP and TrimTab reports on unemployment came in a shade above expectations. The U.S. trade balance improved in November primarily on the drop…
8:45am ET
Investing
5 Top Dividend Yielding Stocks on UBS’s First 2015 Equity Focus List
A new resort from UBS highlights the firm's first Equity Focus list for 2015. Here are five of the highest yielding dividend stocks on the list.
8:20am ET
Investing
Top Analyst Upgrades and Downgrades: Akamai, Carnival, Chevron, Pollo Loco, Ford, F5, Lululemon, Starbucks and More
Monday's top analyst upgrades, downgrades and initiations include Akamai Technologies, Carnival, Chevron, El Pollo Loco, Ford, F5 Networks, Lululemon Athletica and Starbucks.
10:05am ET
Health and Healthcare
5 Top Pharmaceutical Stock Picks for 2015
In a new research report, the SunTrust Robinson Humphrey team highlights the top pharmaceutical stocks to buy for 2015.
11:25am ET
Investing
Great Dividends: Meet the Preliminary 2015 Dogs of the Dow
With investors loving dividends so much, 24/7 always tries to take a look at what the Dogs of the Dow will look like for the year ahead.
2:58pm ET
Health and Healthcare
Merrill Lynch’s Top Health Care Stock Picks for 2015
24/7 Wall St. has compiled a list health care stocks that Merrill Lynch expects to be top performers in 2015.
4:01pm ET
Investing
The 4 Stocks That Weighed on Monday’s Market
thinkstockDecember 15, 2014: Markets opened higher on Monday following a strong report on industrial production that was later describe as a catch-up phase from previous growth. But the big drag appears to…
4:01pm ET
Investing
The 4 Stocks That Weighed on Tuesday’s Market
thinkstockDecember 9, 2014: Markets opened lower on Tuesday following a sharp decline overnight in the Shanghai Composite after China’s central bank tightened up liquidity restrictions. A better than expected job openings report…
8:50am ET
Health and Healthcare
After Big Cubist Buy, Are These 2 Stocks Next to Be Acquired?
SunTrust Robinson Humphrey analysts say in a research note that Achaogen and Cempra could be in play as acquisition targets.
Lee Jackson 8:20am ET
Health and Healthcare
Merck, Cubist Agree to $9.5 Billion Acquisition
Merck will acquire Cubist for $102 a share, or, about $9.5 billion, including $1.1 billion in Cubist’s net debt and other items.
Paul Ausick 9:15am ET
Health and Healthcare
Big News for Ebola Stocks
Monday may have started out as a fairly quiet news day for most stock sectors on a shortened week, but don't tell that to the Ebola drug stocks.
9:10am ET
Companies and Brands
Companies Spending the Most on R&D
For the third consecutive year, the company spending the most on research and development (R&D) was Germany's Volkswagen.